1. Home
  2. GEL vs SPRY Comparison

GEL vs SPRY Comparison

Compare GEL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • SPRY
  • Stock Information
  • Founded
  • GEL 1996
  • SPRY 2015
  • Country
  • GEL United States
  • SPRY United States
  • Employees
  • GEL N/A
  • SPRY N/A
  • Industry
  • GEL Oil Refining/Marketing
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • SPRY Health Care
  • Exchange
  • GEL Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • GEL 1.3B
  • SPRY 1.1B
  • IPO Year
  • GEL 1996
  • SPRY N/A
  • Fundamental
  • Price
  • GEL $11.97
  • SPRY $11.24
  • Analyst Decision
  • GEL Buy
  • SPRY Strong Buy
  • Analyst Count
  • GEL 2
  • SPRY 4
  • Target Price
  • GEL $16.00
  • SPRY $26.00
  • AVG Volume (30 Days)
  • GEL 777.6K
  • SPRY 1.2M
  • Earning Date
  • GEL 02-13-2025
  • SPRY 03-20-2025
  • Dividend Yield
  • GEL 5.50%
  • SPRY N/A
  • EPS Growth
  • GEL N/A
  • SPRY N/A
  • EPS
  • GEL N/A
  • SPRY N/A
  • Revenue
  • GEL $2,966,216,000.00
  • SPRY $2,568,000.00
  • Revenue This Year
  • GEL $2.12
  • SPRY $68,783.34
  • Revenue Next Year
  • GEL $5.38
  • SPRY $503.87
  • P/E Ratio
  • GEL N/A
  • SPRY N/A
  • Revenue Growth
  • GEL N/A
  • SPRY 8460.00
  • 52 Week Low
  • GEL $9.86
  • SPRY $7.55
  • 52 Week High
  • GEL $15.17
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • GEL 61.88
  • SPRY 37.72
  • Support Level
  • GEL $11.92
  • SPRY $11.58
  • Resistance Level
  • GEL $11.28
  • SPRY $12.43
  • Average True Range (ATR)
  • GEL 0.44
  • SPRY 0.72
  • MACD
  • GEL 0.16
  • SPRY -0.14
  • Stochastic Oscillator
  • GEL 78.69
  • SPRY 0.53

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: